FT Options’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

FT Options’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-27,700	Closed	-$158K	–	449
2016 Q3	$158K	Sell	27,700 -14,400	-34%	-$102K	0.13%	121
2016 Q2	$23K	Buy	+42,100	New	+$216K	0.02%	248
2016 Q1	–	Sell	-198,100	Closed	-$9K	–	387
2015 Q4	$9K	Buy	+198,100	New	+$1.15M	0.01%	184

FT Options's RPTP Position: Q1 2016 in Review

FT Options sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 8,568 shares — an estimated $45K sold.

FT Options first reported a position in RPTP in Q4 2015 and held it in 1 quarter. The position peaked at $45K in Q4 2015. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

FT Options reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
FT Options sold 8,568 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $45K.
FT Options first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 1 quarter.
FT Options's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $45K in Q4 2015.
97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on FT Options's 13F filing for Q1 2016, filed 9 May 2016.